Get the Stockscreener App
2.01
1.01%
0.02
Zura Bio Ltd stock is traded at $2.01, with a volume of 585.01K.
It is up +1.01% in the last 24 hours and up +19.64% over the past month.
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
See More
Previous Close:
$1.99
Open:
$2.01
24h Volume:
585.01K
Relative Volume:
0.81
Market Cap:
$130.69M
Revenue:
-
Net Income/Loss:
$-60.36M
P/E Ratio:
-0.4574
EPS:
-4.394
Net Cash Flow:
$-15.05M
1W Performance:
+21.08%
1M Performance:
+19.64%
6M Performance:
+43.57%
1Y Performance:
-43.38%
1-Day Range:
$1.91
$2.085
1-Week Range:
$1.6604
$2.085
52-Week Range:
$0.97
$5.07
Zura Bio Ltd Stock (ZURA) Company Profile
Name
Zura Bio Ltd
Sector
Industry
Phone
858-247-0520
Address
4225 EXECUTIVE SQUARE, LA JOLLA
Compare ZURA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZURA
Zura Bio Ltd
|
2.01 | 113.13M | 0 | -60.36M | -15.05M | -4.394 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Zura Bio Ltd Stock (ZURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-24 | Initiated | Leerink Partners | Outperform |
| Sep-05-24 | Initiated | H.C. Wainwright | Neutral |
| May-03-24 | Initiated | Piper Sandler | Overweight |
| Oct-10-23 | Initiated | Ladenburg Thalmann | Buy |
| Aug-25-23 | Initiated | Oppenheimer | Outperform |
| Jun-22-23 | Initiated | Guggenheim | Buy |
| Jun-14-23 | Initiated | Chardan Capital Markets | Buy |
| May-24-23 | Initiated | Raymond James | Strong Buy |
View All
Zura Bio Ltd Stock (ZURA) Latest News
Is Zura Bio Limited stock ready for a breakout2025 Biggest Moves & Real-Time Volume Triggers - Newser
Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference - Yahoo Finance
Analyzing net buyer seller activity in Zura Bio LimitedJuly 2025 Catalysts & Consistent Income Trade Recommendations - Newser
Zura Bio (NASDAQ:ZURA) Price Target Cut to $2.00 by Analysts at HC Wainwright - Defense World
Is it too late to sell Zura Bio LimitedEarnings Trend Report & Verified Technical Trade Signals - Newser
Will Zura Bio Limited stock recover after recent dropWatch List & Momentum Based Trading Ideas - Newser
Price action breakdown for Zura Bio LimitedMarket Performance Recap & Capital Efficiency Focused Ideas - Newser
What recovery options are there for Zura Bio LimitedEarnings Recap Summary & Consistent Income Trade Ideas - Newser
Statistical indicators supporting Zura Bio Limited’s strengthDip Buying & Verified Swing Trading Watchlist - Newser
Advanced analytics toolkit walkthrough for Zura Bio LimitedJuly 2025 Intraday Action & AI Powered Buy and Sell Recommendations - Newser
Oppenheimer Lowers Zura Bio (NASDAQ:ZURA) Price Target to $16.00 - Defense World
Heatmap analysis for Zura Bio Limited and competitorsWall Street Watch & Long-Term Capital Growth Strategies - Newser
Multi factor analysis applied to Zura Bio LimitedMarket Movement Recap & Consistent Profit Trading Strategies - Newser
Is Zura Bio Limited stock reversal real or fake2025 Top Decliners & Safe Capital Growth Trade Ideas - Newser
Is Zura Bio Limited stock a smart retirement pickJuly 2025 Drop Watch & Smart Investment Allocation Tips - 선데이타임즈
Zura Bio: Oppenheimer maintains Outperform, lowers PT to $16 from $17. - AInvest
Oppenheimer lowers Zura Bio stock price target to $16 on clinical updates - Investing.com Nigeria
Will Zura Bio Limited benefit from AI trendsProduct Launch & Smart Investment Allocation Insights - 선데이타임즈
Chardan Capital raises Zura Bio's PT to $10 from $8. - AInvest
Real time scanner hits for Zura Bio Limited explainedChart Signals & Safe Capital Investment Plans - Newser
Zura Bio Limited Reports Q2 2025 Financial Results - TipRanks
Leerink Partners reiterates Outperform rating on Zura Bio stock - Investing.com
Leerink Partners reiterates Outperform rating on Zura Bio stock By Investing.com - Investing.com Nigeria
Zura Bio Ltd SEC 10-Q Report - TradingView
Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates - TradingView
Will Zura Bio Limited continue its uptrendFree Breakout Momentum Picks With Protection - Newser
Novartis Drug Shows Improvement In Sjögren’s Disease In Late-Stage Trials: Analyst Deems Data Positive For Zura Bio As Well By Stocktwits - Investing.com India
Ranking Zura Bio Limited among high performing stocks via toolsTactical Trade Setup With Entry Optimizer - Newser
Zura Bio Ltd expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Is Zura Bio Limited a candidate for recovery playRisk Managed Watchlist with Breakout Picks - Newser
Analysts Set Zura Bio Limited (NASDAQ:ZURA) Target Price at $14.33 - Defense World
Ranking Entera Bio Ltd. among high performing stocks via toolsWatchlist Summary for Active Day Traders - Newser
Can Zura Bio Limited hit a new high this monthBuy Point Strategy with Profit Protection - Newser
What indicators show strength in Zura Bio LimitedPattern Recognition Based Market Move Prediction - Newser
What drives Zura Bio Limited stock priceCapitalize on market trends with confidence - Jammu Links News
Is it the right time to buy Zura Bio Limited stockUnlock your trading potential today - Jammu Links News
Published on: 2025-08-01 00:02:11 - Newser
What makes Zura Bio Limited stock price move sharplyAI Intraday Market Movement Prediction Tool - Newser
Why is Zura Bio Limited stock attracting strong analyst attentionSmart Portfolio Recommendation For Beginners - Jammu Links News
Chart based analysis of Zura Bio Limited trendsLong Term Stock Growth Plan Suggestions - Newser
Can machine learning forecast Zura Bio Limited recoveryAlgorithmic Prediction of Market Breakouts - Newser
Is Zura Bio Limited a growth stock or a value stockEntry Signal Guidance That Work - Jammu Links News
How Zura Bio Limited stock performs during market volatilityNext Day Momentum Stock Forecasting Report - Newser
What markets is Zura Bio Limited expanding into Is NEE.PRT stock a good long term investment optionPhenomenal capital appreciation - jammulinksnews.com
Is Zura Bio Limited Stock Overbought or Oversold RSI Indicator AnalysisShort-Term Upside Breakout Forecast System - Newser
What are Zura Bio Limited company’s key revenue driversStock Market Report For Consistent Profits - Jammu Links News
How strong is Waton Financial Limited company’s balance sheetMarket-beating performance - Jammu Links News
Is Zura Bio Limited a good long term investmentDynamic profit opportunities - PrintWeekIndia
Published on: 2025-07-25 23:30:16 - PrintWeekIndia
What analysts say about Zura Bio Limited stockConsistent high-yield stocks - jammulinksnews.com
Zura Bio Ltd Stock (ZURA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Zura Bio Ltd Stock (ZURA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Thiara Parvinder | Director |
Sep 11 '24 |
Sale |
2.70 |
3,800,000 |
10,260,000 |
1,001,633 |
| Sidhu Someit | Director |
Sep 04 '24 |
Sale |
3.87 |
51,728 |
200,187 |
2,085,418 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):